University Of Florence

This study looks at how well the drug rimegepant works to prevent migraines in 100 people with episodic or chronic migraine. Participants will take rimegepant and report changes in their monthly migraine days over three to twelve months. The goal is to see if the drug reduces mig…

This study tests a short talk therapy called Well-Being Therapy (WBT) in 30 adults with chronic migraine. The goal is to see if WBT can reduce migraine-related disability, pain, and distress while boosting overall well-being. Participants will be randomly assigned to WBT or a con…

This study is testing a drug called rimegepant to see how well it stops migraine pain and if it causes side effects. About 100 adults with migraines will take the pill during an attack and report their pain levels. The goal is to find a fast, effective treatment for migraine suff…

This study looks at whether the migraine drug eptinezumab can stop a migraine attack while it is being infused. Researchers will measure how quickly headache pain and other bothersome symptoms go away. The study involves 50 adults with migraine who are already receiving eptinezum…

This study looks at whether a program that combines counseling and museum visits can help people with fibromyalgia, a condition causing widespread pain and emotional distress. Researchers will first assess participants' mental and physical health, then offer a therapy that includ…